Literature DB >> 24280991

Exome sequencing finds a novel PCSK1 mutation in a child with generalized malabsorptive diarrhea and diabetes insipidus.

Michael Yourshaw1, R Sergio Solorzano-Vargas, Lindsay A Pickett, Iris Lindberg, Jiafang Wang, Galen Cortina, Anna Pawlikowska-Haddal, Howard Baron, Robert S Venick, Stanley F Nelson, Martín G Martín.   

Abstract

OBJECTIVES: Congenital diarrhea disorders are a group of genetically diverse and typically autosomal recessive disorders that have yet to be well characterized phenotypically or molecularly. Diagnostic assessments are generally limited to nutritional challenges and histologic evaluation, and many subjects eventually require a prolonged course of intravenous nutrition. Here we describe next-generation sequencing techniques to investigate a child with perplexing congenital malabsorptive diarrhea and other presumably unrelated clinical problems; this method provides an alternative approach to molecular diagnosis.
METHODS: We screened the diploid genome of an affected individual, using exome sequencing, for uncommon variants that have observed protein-coding consequences. We assessed the functional activity of the mutant protein, as well as its lack of expression using immunohistochemistry.
RESULTS: Among several rare variants detected was a homozygous nonsense mutation in the catalytic domain of the proprotein convertase subtilisin/kexin type 1 gene. The mutation abolishes prohormone convertase 1/3 endoprotease activity as well as expression in the intestine. These primary genetic findings prompted a careful endocrine reevaluation of the child at 4.5 years of age, and multiple significant problems were subsequently identified consistent with the known phenotypic consequences of proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations. Based on the molecular diagnosis, alternate medical and dietary management was implemented for diabetes insipidus, polyphagia, and micropenis.
CONCLUSIONS: Whole-exome sequencing provides a powerful diagnostic tool to clinicians managing rare genetic disorders with multiple perplexing clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24280991      PMCID: PMC4170062          DOI: 10.1097/MPG.0b013e3182a8ae6c

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  48 in total

Review 1.  Predicting the effects of amino acid substitutions on protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

2.  Causes of chronic diarrhea.

Authors:  Henry J Binder
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

3.  Enteroendocrine cell dysgenesis and malabsorption, a histopathologic and immunohistochemical characterization.

Authors:  Galen Cortina; Chandra N Smart; Douglas G Farmer; Sunita Bhuta; William R Treem; Ivor D Hill; Martín G Martín
Journal:  Hum Pathol       Date:  2007-01-29       Impact factor: 3.466

4.  Regulatory roles of the P domain of the subtilisin-like prohormone convertases.

Authors:  A Zhou; S Martin; G Lipkind; J LaMendola; D F Steiner
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

5.  Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function.

Authors:  S O'Rahilly; H Gray; P J Humphreys; A Krook; K S Polonsky; A White; S Gibson; K Taylor; C Carr
Journal:  N Engl J Med       Date:  1995-11-23       Impact factor: 91.245

6.  Mutant neurogenin-3 in congenital malabsorptive diarrhea.

Authors:  Jiafang Wang; Galen Cortina; S Vincent Wu; Robert Tran; Jang-Hyeon Cho; Ming-Jer Tsai; Travis J Bailey; Milan Jamrich; Marvin E Ament; William R Treem; Ivor D Hill; Jorge H Vargas; George Gershman; Douglas G Farmer; Laurie Reyen; Martín G Martín
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

7.  Common nonsynonymous variants in PCSK1 confer risk of obesity.

Authors:  Michael Benzinou; John W M Creemers; Helene Choquet; Stephane Lobbens; Christian Dina; Emmanuelle Durand; Audrey Guerardel; Philippe Boutin; Beatrice Jouret; Barbara Heude; Beverley Balkau; Jean Tichet; Michel Marre; Natascha Potoczna; Fritz Horber; Catherine Le Stunff; Sebastien Czernichow; Annelli Sandbaek; Torsten Lauritzen; Knut Borch-Johnsen; Gitte Andersen; Wieland Kiess; Antje Körner; Peter Kovacs; Peter Jacobson; Lena M S Carlsson; Andrew J Walley; Torben Jørgensen; Torben Hansen; Oluf Pedersen; David Meyre; Philippe Froguel
Journal:  Nat Genet       Date:  2008-07-06       Impact factor: 38.330

8.  Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption.

Authors:  M G Martín; E Turk; M P Lostao; C Kerner; E M Wright
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

Review 9.  The proprotein convertases.

Authors:  D F Steiner
Journal:  Curr Opin Chem Biol       Date:  1998-02       Impact factor: 8.822

10.  Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3.

Authors:  I Sadaf Farooqi; Karolien Volders; Richard Stanhope; Robert Heuschkel; Anne White; Emma Lank; Julia Keogh; Stephen O'Rahilly; John W M Creemers
Journal:  J Clin Endocrinol Metab       Date:  2007-06-26       Impact factor: 5.958

View more
  10 in total

1.  Rich annotation of DNA sequencing variants by leveraging the Ensembl Variant Effect Predictor with plugins.

Authors:  Michael Yourshaw; S Paige Taylor; Aliz R Rao; Martín G Martín; Stanley F Nelson
Journal:  Brief Bioinform       Date:  2014-03-12       Impact factor: 11.622

2.  The G209R mutant mouse as a model for human PCSK1 polyendocrinopathy.

Authors:  Manita Shakya; Surbhi Gahlot; Nicolle K Martin; Anoop Arunagiri; Martin G Martin; Peter Arvan; Malcolm J Low; Iris Lindberg
Journal:  Endocrinology       Date:  2022-03-04       Impact factor: 5.051

3.  Common variants in PCSK1 influence blood pressure and body mass index.

Authors:  Q Gu; M Yazdanpanah; M van Hoek; A Hofman; X Gao; F W M de Rooij; E J G Sijbrands
Journal:  J Hum Hypertens       Date:  2014-07-17       Impact factor: 3.012

Review 4.  PCSK1 Variants and Human Obesity.

Authors:  B Ramos-Molina; M G Martin; I Lindberg
Journal:  Prog Mol Biol Transl Sci       Date:  2016-01-29       Impact factor: 3.622

5.  Defective transport of the obesity mutant PC1/3 N222D contributes to loss of function.

Authors:  Yogikala Prabhu; Elias H Blanco; Ming Liu; Juan R Peinado; Matthew C Wheeler; Nicholas Gekakis; Peter Arvan; Iris Lindberg
Journal:  Endocrinology       Date:  2014-05-14       Impact factor: 4.736

Review 6.  Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies.

Authors:  Roberto Berni Canani; Giuseppe Castaldo; Rosa Bacchetta; Martín G Martín; Olivier Goulet
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 73.082

Review 7.  Obesity genetics in mouse and human: back and forth, and back again.

Authors:  Fereshteh T Yazdi; Susanne M Clee; David Meyre
Journal:  PeerJ       Date:  2015-03-24       Impact factor: 2.984

8.  A novel familial mutation in the PCSK1 gene that alters the oxyanion hole residue of proprotein convertase 1/3 and impairs its enzymatic activity.

Authors:  Michael Wilschanski; Montaser Abbasi; Elias Blanco; Iris Lindberg; Michael Yourshaw; David Zangen; Itai Berger; Eyal Shteyer; Orit Pappo; Benjamin Bar-Oz; Martin G Martín; Orly Elpeleg
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

9.  Enteroendocrine Dysfunction in Two Saudi Sisters.

Authors:  Amna Basheer M Ahmed; Badr M Rasheed Alsaleem
Journal:  Case Rep Gastroenterol       Date:  2021-03-04

Review 10.  Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature.

Authors:  Hadley Stevens Smith; J Michael Swint; Seema R Lalani; Jose-Miguel Yamal; Marcia C de Oliveira Otto; Stephan Castellanos; Amy Taylor; Brendan H Lee; Heidi V Russell
Journal:  Genet Med       Date:  2018-05-14       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.